Adjuvant endocrine therapy after breast cancer: a qualitative study of factors associated with adherence.

about

Adjuvant endocrine therapy after breast cancer: a qualitative study of factors associated with adherence.

Item

http://www.wikidata.org/entity/Q50357148

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Adjuvant endocrine therapy aft ...... ors associated with adherence.

@en

Adjuvant endocrine therapy aft ...... ors associated with adherence.

@nl

type

Item

label

Adjuvant endocrine therapy aft ...... ors associated with adherence.

@en

Adjuvant endocrine therapy aft ...... ors associated with adherence.

@nl

prefLabel

Adjuvant endocrine therapy aft ...... ors associated with adherence.

@en

Adjuvant endocrine therapy aft ...... ors associated with adherence.

@nl

P1476

Adjuvant endocrine therapy aft ...... ors associated with adherence.

@en

P2093

Adrienne Morgan

http://www.w3.org/2001/XMLSchema#string

Bernadette A Lavery

http://www.w3.org/2001/XMLSchema#string

Carolyn Morris

http://www.w3.org/2001/XMLSchema#string

Debbie Fenlon

http://www.w3.org/2001/XMLSchema#string

Eila K Watson

http://www.w3.org/2001/XMLSchema#string

Jo Brett

http://www.w3.org/2001/XMLSchema#string

Mary Boulton

http://www.w3.org/2001/XMLSchema#string

Nick J Hulbert-Williams

http://www.w3.org/2001/XMLSchema#string

Peter Donnelly

http://www.w3.org/2001/XMLSchema#string

P2860

Interventional tools to improve medication adherence: review of literature

How do we improve patient compliance and adherence to long-term statin therapy?

Adherence to Medication

The psychosocial experience of patients with end-stage renal disease and its impact on quality of life: findings from a needs assessment to shape a service.

A hard pill to swallow: a qualitative study of women's experiences of adjuvant endocrine therapy for breast cancer.

Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer.

Adherence beliefs among breast cancer patients taking tamoxifen.

Medication adherence: WHO cares?

Understanding patients' adherence-related beliefs about medicines prescribed for long-term conditions: a meta-analytic review of the Necessity-Concerns Framework

Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial

P304

291-300

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/PPA.S145784

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Fiona M Walter

P577

2018-02-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29497284

http://www.w3.org/2001/XMLSchema#string

P932

5819578

http://www.w3.org/2001/XMLSchema#string